Amendment No. 5 to Schedule 13D for Vor Biopharma Inc.

This Amendment No. 5 to Schedule 13D, filed by Reprogrammed Interchange LLC and Reid Hoffman, updates the previously filed Schedule 13D and its amendments. The filing reports significant changes in the ownership of Vor Biopharma Inc.'s common stock. Specifically, Reprogrammed Interchange LLC sold 70,763 shares on October 6, 2025, and 27,624 shares on October 7, 2025, at weighted average prices of $37.0079 and $33.8369 per share, respectively. These transactions resulted in a decrease of more than one percent in the number of shares beneficially owned by the Reporting Persons. The filing also details additional sales of shares over the past 60 days, reflecting the impact of a 1-for-20 reverse stock split of Vor Biopharma Inc. Common Stock effected on September 18, 2025. The Reporting Persons collectively own 21.9% of the outstanding shares of Common Stock of the Issuer.